Elite Pharmaceuticals, Inc. (ELTP)
0.2468
0.00 (0.00%)
USD |
OTCM |
Sep 24, 16:00
Elite Pharmaceuticals Price to Book Value : 2.536 for Sept. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 24, 2026 | 2.536 |
| September 23, 2026 | 2.558 |
| September 22, 2026 | 2.538 |
| September 21, 2026 | 2.489 |
| September 18, 2026 | 2.543 |
| September 17, 2026 | 2.568 |
| September 16, 2026 | 2.517 |
| September 15, 2026 | 2.556 |
| September 14, 2026 | 2.670 |
| September 11, 2026 | 2.702 |
| September 10, 2026 | 2.580 |
| September 09, 2026 | 2.642 |
| September 08, 2026 | 2.671 |
| September 04, 2026 | 2.651 |
| September 03, 2026 | 2.683 |
| September 02, 2026 | 2.838 |
| September 01, 2026 | 2.925 |
| August 31, 2026 | 2.954 |
| August 28, 2026 | 2.968 |
| August 27, 2026 | 2.959 |
| August 26, 2026 | 2.928 |
| August 25, 2026 | 2.939 |
| August 24, 2026 | 2.971 |
| August 21, 2026 | 3.031 |
| August 20, 2026 | 3.056 |
| Date | Value |
|---|---|
| August 19, 2026 | 3.113 |
| August 18, 2026 | 3.119 |
| August 17, 2026 | 3.165 |
| August 14, 2026 | 3.185 |
| August 13, 2026 | 3.684 |
| August 12, 2026 | 3.699 |
| August 11, 2026 | 3.709 |
| August 10, 2026 | 3.700 |
| August 07, 2026 | 3.709 |
| August 06, 2026 | 3.676 |
| August 05, 2026 | 3.708 |
| August 04, 2026 | 3.750 |
| August 03, 2026 | 3.818 |
| July 31, 2026 | 3.893 |
| July 30, 2026 | 3.830 |
| July 29, 2026 | 3.818 |
| July 28, 2026 | 3.853 |
| July 27, 2026 | 3.956 |
| July 24, 2026 | 3.982 |
| July 23, 2026 | 3.853 |
| July 22, 2026 | 3.833 |
| July 21, 2026 | 3.894 |
| July 20, 2026 | 3.956 |
| July 17, 2026 | 3.989 |
| July 16, 2026 | 4.100 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Nektar Therapeutics | 2.158 |
| Daré Bioscience, Inc. | -- |
| Eton Pharmaceuticals, Inc. | 35.03 |
| ANI Pharmaceuticals, Inc. | 2.846 |
| Corcept Therapeutics, Inc. | 17.77 |
Price to Book Value Related Metrics
| PE Ratio | 9.383 |
| PS Ratio | 1.964 |
| Price to Free Cash Flow | 15.80 |
| Price | 0.2468 |
| Earnings Yield | 10.66% |
| Market Cap | 265.82M |
| Operating PE Ratio | 7.737 |
| Normalized PE Ratio | 30.47 |